Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 08/25 05:35:19 pm
1653 GBp   -0.33%
08/25 GLAXOSMITHKLINE : GSK) Unveils Take 5 for Meningitis
08/25 INSIDE THE FDA : Frontrunners Merck & Co., Inc. (NYSE:MRK), GlaxoSm..
08/22 UK dividends lagging behind UK
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline plc : Director/PDMR Shareholding

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 08:11pm CEST

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of a Person Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc ("Ordinary Shares") on 2 May 2012:

Mr S M Bicknell

Transfer of 250 Ordinary Shares into an ISA at £14.3225 per share.



The Company and the above mentioned person was advised of this transaction on 3 May 2012.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 May 2012


This information is provided by RNS
The company news service from the London Stock Exchange
ENDRDSQXLFBLEFXBBD
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLAXOSMITHKLINE PLC
08/25 GLAXOSMITHKLINE PLC (NYSE : GSK) Unveils Take 5 for Meningitis
08/25 INSIDE THE FDA EBOLA EDITION : Frontrunners Merck & Co., Inc. (NYSE:MRK), GlaxoS..
08/24 GLAXOSMITHKLINE PAKISTAN : Board meeting of GlaxoSmithKline Pakistan Limited to ..
08/22 UK dividends lagging behind UK
08/22 UK dividends lagging behind
08/20 Cipla, godrej recognised in fortune `change the world' list
08/19 GLAXOSMITHKLINE PAKISTAN : Board meeting of GlaxoSmithKline Pakistan Limited to ..
08/19 Cipla, godrej consumer products in fortune's `change the world' list
08/18 Charles River Laboratories Announces Partnership with the Milner Therapeutics..
08/18 GlaxoSmithKline Sells Dermatology Foam Products Portfolio To Mayne
More news
Sector news : Pharmaceuticals - NEC
08/25 FTSE retreats as pharma stocks fall
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting -- 3rd Update
08/25DJMylan Boosts Price Assistance for EpiPen Amid Backlash
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/23 10 HIV+ patients from CytoDyn's mid-stage study reach two years of complete v..
08/16 Biotechnology Dogs Move Big Pharma Off Healthcare Top Slots In August
08/16 CVRx Holds Its Nerve
08/16 Inovio Zika Phase 1 Clinical Trial Design Superior To NIH Zika Phase 1 Clinic..
08/16 ViiV Healthcare initiates late-stage development of two-drug HIV regimen
Advertisement
Financials ( GBP)
Sales 2016 26 815 M
EBIT 2016 7 264 M
Net income 2016 2 682 M
Debt 2016 13 195 M
Yield 2016 4,82%
P/E ratio 2016 35,25
P/E ratio 2017 21,83
EV / Sales 2016 3,51x
EV / Sales 2017 3,68x
Capitalization 80 848 M
More Financials
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 26
Average target price 17,2  GBP
Spread / Average Target 3,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Andrew Philip Witty Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Moncef Slaoui Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC21.19%106 869
JOHNSON & JOHNSON15.57%324 776
ROCHE HOLDING LTD.-11.47%217 694
NOVARTIS AG-9.45%213 882
PFIZER INC.7.87%211 206
MERCK & CO., INC.18.76%173 462
More Results